Spojené státy - angličtina - NLM (National Library of Medicine)

akorn - hydralazine hydrochloride (unii: fd171b778y) (hydralazine - unii:26nak24ls8) - severe essential hypertension when the drug cannot be given orally or when there is an urgent need to lower blood pressure. hypersensitivity to hydralazine; coronary artery disease; mitral valvular rheumatic heart disease.

Spojené státy - angličtina - NLM (National Library of Medicine)

akorn - cyclopentolate hydrochloride (unii: 736i6971te) (cyclopentolate - unii:i76f4shp7j) - cyclopentolate hydrochloride ophthalmic solution is used to produce mydriasis and cycloplegia. cyclopentolate hydrochloride ophthalmic solution should not be used when untreated narrow-angle glaucoma, or untreated anatomically narrow angles are present, or if the patient is hypersensitive to any component of this preparation.

Spojené státy - angličtina - NLM (National Library of Medicine)

akorn, inc. - bacitracin a (unii: dda3rrx0p7) (bacitracin a - unii:dda3rrx0p7) - in accordance with the statements in the "warning box", the use of intramuscular bacitracin for injection, usp is limited to the treatment of infants with pneumonia and empyema caused by staphylococci shown to be susceptible to the drug. to reduce the development of drug-resistant bacteria and maintain the effectiveness of bacitracin for injection, usp and other antibacterial drugs, bacitracin for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is contraindicated in those individuals with a history of previous hypersensitivity or toxic reaction to it.

Spojené státy - angličtina - NLM (National Library of Medicine)

akorn, inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - dehydrated alcohol injection, usp is indicated for therapeutic neurolysis of nerves or ganglia for the relief of intractable chronic pain in such conditions as inoperable cancer and trigeminal neuralgia (tic douloureux), in patients for whom neurosurgical procedures are contraindicated. relief of trigeminal neuralgia usually is only temporary. other conditions for which injection of alcohol has been reported include glossopharyngeal neuralgia, angina pectoris and severe claudication due to peripheral vascular insufficiency. alcohol concentrations of 40 to 50% (prepared by appropriate dilution of dehydrated alcohol) have been used for epidural or individual motor nerve injections to control certain manifestations of cerebral palsy and spastic paraplegia. similar concentrations also have been injected for celiac plexus block to relieve pain of inoperable upper abdominal cancer, and have been injected intra-and subcutaneously for relief of intractable pruritus ani. subarachnoid injection of dehydrated alcohol is

Spojené státy - angličtina - NLM (National Library of Medicine)

akorn - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to erythromycin. for prophylaxis of ophthalmia neonatorum due to n. gonorrhoeae or c. trachomatis . the effectiveness of erythromycin in the prevention of ophthalmia caused by penicillinase-producing n.gonorrhoeae is not established. for infants born to mothers with clinically apparent gonorrhea, intravenous or intramuscular injections of aqueous crystalline penicillin g should be given; a single dose of 50,000 units for term infants or 20,000 units for infants of low birth weight. topical prophylaxis alone is inadequate for these infants. this drug is contraindicated in patients with a history of hypersensitivity to erythromycin.

Spojené státy - angličtina - NLM (National Library of Medicine)

akorn - methylergonovine maleate (unii: ir84jpz1rk) (methylergonovine - unii:w53l6fe61v) - following delivery of the placenta, for routine management of uterine atony, hemorrhage and subinvolution of the uterus. for control of uterine hemorrhage in the second stage of labor following delivery of the anterior shoulder. hypertension; toxemia; pregnancy; and hypersensitivity. methylergonovine maleate has not been associated with drug abuse or dependence of either a physical or psychological nature.

Spojené státy - angličtina - NLM (National Library of Medicine)

akorn - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698, sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698), sodium acetate (unii: 4550k0sc9b) (acetate ion - unii:569dqm74sc, sodium cation - uni - for use as an extraocular and intraocular irrigating solution during ocular surgical procedure involving perfusion of the eye with an expected maximum duration of less than 60 minutes.

Spojené státy - angličtina - NLM (National Library of Medicine)

akorn - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9) - orphenadrine citrate injection is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. the mode of action of the drug has not been clearly identified, but may be related to its analgesic properties. orphenadrine citrate does not directly relax tense skeletal muscles in man. contraindicated in patients with glaucoma, pyloric or duodenal obstruction, stenosing peptic ulcers, prostatic hypertrophy or obstruction of the bladder neck, cardio-spasm (megaesophagus) and myasthenia gravis. contraindicated in patients who have demonstrated a previous hypersensitivity to the drug. orphenadrine has been chronically abused for its euphoric effects. the mood elevating effects may occur at therapeutic doses of orphenadrine.

Spojené státy - angličtina - NLM (National Library of Medicine)

akorn - indocyanine green (unii: ix6j1063hv) (indocyanine green acid form - unii:c4v974v932) - indocyanine green 25 mg - ic-green® is indicated: ic-green® contains sodium iodide and should be used with caution in patients who have a history of allergy to iodides because of the risk of anaphylaxis. animal reproduction studies have not been conducted with ic-green® . it is also not known whether ic-green® can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. ic-green® should be given to a pregnant woman only if clearly indicated. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when ic-green® is administered to a nursing woman. safety and effectiveness in pediatric patients have been established. see dosage and administration (2) for specific dosing information in pediatric patients. no overall differences in safety or effectiveness have been observed between elderly and younger patients.

Spojené státy - angličtina - NLM (National Library of Medicine)

akorn - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 1 mg in 1 ml - terbutaline sulfate injection, usp is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. terbutaline sulfate has not been approved and should not be used for prolonged tocolysis (beyond 48 -72 hours). in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting. [see boxed warning, prolonged tocolysis .] terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.